Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment

B. Zaric, B. Perin, A. Ilic, J. Stanic, N. Secen, T. Sarcev, M. Antonic (Sremska Kamenica, Republic Of Serbia)

Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Session: Best supportive care and palliation for lung cancer patients
Session type: Thematic Poster Session
Number: 3294
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Zaric, B. Perin, A. Ilic, J. Stanic, N. Secen, T. Sarcev, M. Antonic (Sremska Kamenica, Republic Of Serbia). Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment. Eur Respir J 2010; 36: Suppl. 54, 3294

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015



Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Drug development: news from “hot” early stage clinical trials: personalised immunotherapy for lung cancer
Source: International Congress 2017 – Scientific year in review
Year: 2017


Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care.
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019

Main reasons for a low accrual pattern in clinical trials of patients with advanced stage non-small cell lung cancer (NSCLC)
Source: Annual Congress 2008 - Influence of teaching models on skills and knowledge of medical doctors
Year: 2008


Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I – IIIa nonsmall cell lung cancer conducted by the European lung cancer working party
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003

A single centre review of palliative chemotherapy in newly diagnosed stage IIIb and IV lung cancer patients with good performance status
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013


A phase III randomised trial testing chemotherapy in extensive small-cell lung cancer (SCLC)
Source: International Congress 2016 – Therapeutic trials in lung cancer
Year: 2016

Treatment of patients with advanced non-small-cell lung cancer (NSCLC) with erlotinib: results from clinical practice
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


Current neoadjuvant/adjuvant treatment for advanced stage lung cancer
Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer
Year: 2014

Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015


The big lung trial (BLT): a major randomised trial examining the role of cisplatin-based chemotherapy in all stages of non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting
Source: Eur Respir J 2002; 20: Suppl. 38, 399s
Year: 2002

Immunotherapy with nivolumab in NSCLC: single center experience after one year clinical practice
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017

Lung cancer: clinical presentation and specialist referral time
Source: Eur Respir J 2004; 24: 898-904
Year: 2004



Analysis of lung adenocarcinoma in patients aged 70 and over: The viewpoint of clinical stage, therapeutic modality and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Non-small cell lung cancer – Advanced disease: Barriers to inclusion in clinical trials and its impact on survival
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019
Year: 2020



A preliminary comprehensive hormonal evaluation on a prospective group of patients (pts) with advanced lung cancer
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016